Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 May 20 425 Business combination disclosure
- 27 May 20 425 Business combination disclosure
- 12 May 20 425 Business combination disclosure
- 11 May 20 425 Business combination disclosure
-
30 Apr 20 425 Business combination disclosure
- 25 Mar 20 425 Business combination disclosure
- 17 Mar 20 425 Business combination disclosure
- 16 Mar 20 425 Business combination disclosure
- 16 Mar 20 425 Business combination disclosure
TLPH similar filings
Related company
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No.333-218506) on FormS-3 of AcelRx Pharmaceuticals, Inc. of our report dated March 11, 2020, relating to the consolidated financial statements of Tetraphase Pharmaceuticals, Inc. as of and for the years ended December 31, 2019 and 2018 appearing in this Current Report on Form8-K of AcelRx Pharmaceuticals, Inc.
/s/ Ernst & Young LLP
Boston, Massachusetts
April 30, 2020